We guide pharmaceutical manufacturers in achieving regulatory compliance, enhancing R&D processes, & improving operational efficiency.
Pharmaceutical manufacturing involves the production of medications and drugs. This industry is critical for healthcare and plays a significant role in ensuring public health and wellbeing.
India is known as the “pharmacy of the world” due to its significant contribution to global pharmaceutical manufacturing. The industry is one of the largest in the world, supplying over 50% of global demand for various vaccines. As of 2023, the Indian pharmaceutical market is valued at approximately USD 42 billion and is expected to grow at a CAGR of 12.8% from 2020 to 2025. Major players include Sun Pharmaceuticals, Dr. Reddy’s Laboratories, and Cipla.
The pharmaceutical manufacturing industry in India is expected to continue its growth trajectory due to:
Navigating complex and stringent regulatory requirements.
High costs associated with research and development.
Managing global supply chains and ensuring raw material availability.
Pressure to keep prices low while maintaining profitability.
Combating the prevalence of counterfeit drugs.
Intense competition from domestic and international players.
Protecting intellectual property and patents.
Ensuring consistent quality and safety of products.
Stratefix Consulting provides specialized services for the pharmaceutical manufacturing industry:
Stratefix Consulting has helped numerous pharmaceutical companies achieve remarkable results. For instance, we assisted a major pharmaceutical manufacturer in optimizing their supply chain, reducing costs by 20%. We also guided a company through the complexities of regulatory compliance, enabling them to enter new international markets. By providing tailored solutions and hands-on support, Stratefix has enabled pharmaceutical companies to achieve significant improvements in performance and profitability.